Needham analyst Mike Matson downgraded TransMedics Group (NASDAQ: TMDX) from Buy to Hold.The analyst comments "Our checks indicate that TMDX ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE